Condition

Peritoneal Dialysis

ClinicalTrials.gov condition label

Clinical trials11

Recruiting2

Common interventions12

Lead sponsors shown10

Clinical trials

11 shown

Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic PatientsNCT07077538 · 2025-07-30

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis PatientsNCT07271420 · 2020-01-01

Continuous Glucose Monitoring in Dialysis Patients With DiabetesNCT06641765 · 2024-11-01

ACTIVE_NOT_RECRUITING

The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis PatientsNCT06697418 · 2024-10-01

ENROLLING_BY_INVITATION

Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal DiseaseNCT06330194 · 2024-04-18

Continuous Glucose Monitoring in Patients With Diabetes on Peritoneal DialysisNCT06069518 · 2023-11-01

Isoflavones and Peritoneal DialysisNCT04185168 · 2019-11-16

A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin TherapyNCT03320031 · 2017-06-03

Treatment of Asymptomatic Fluid Overload in Peritoneal Dialysis PatientsNCT02168283 · 2015-12-01

Changes in Cardiovascular Hemodynamics During Peritoneal DialysisNCT00119990 · 2006-01-01

Evaluation of Volume Status in Peritoneal Dialysis PatientsNCT00182338 · 2005-01-01

Common interventions

2nd Generation Automated Insulin Delivery (AID) systemDEVICE1 Amino acid peritoneal dialysis solutionDRUG1 Continous Glucose MonitoringDEVICE1 controlOTHER1 Control armBEHAVIORAL1 Humalog Mix 75/25DRUG1 Hydrochlorothiazide 25mg once per dayDRUG1 Icodextrin (dialysate)DRUG1 LinagliptinDRUG1 Physioneal (dialysate) 1.36% and 2.27%DRUG1 soy isoflavoneDIETARY_SUPPLEMENT1 treatment armCOMBINATION_PRODUCT1

Leading sponsors

Chinese University of Hong Kong2 Bo Feldt-Rasmussen1 Coordinación de Investigación en Salud, Mexico1 McMaster University1 National Nutrition and Food Technology Institute1 Ruijin Hospital1 Steno Diabetes Center Copenhagen1 The People's Hospital of Gaozhou1 University of Aarhus1 Yanbing Li1

Trial status mix

COMPLETED3

RECRUITING2

UNKNOWN2

ACTIVE_NOT_RECRUITING1

ENROLLING_BY_INVITATION1

TERMINATED1

WITHDRAWN1

Phase mix

NA5

PHASE43

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.